Projects funded by the NCN

New hybrid compounds derived from 2-(2,5-dioxopyrrolidin-1-yl)-propanamide in the search for substances effective in tre...

Call: PRELUDIUM 15 , Panel: NZ7

Principal investigator: Michał Abram

Uniwersytet Jagielloński - Collegium Medicum, Collegium Medicum, Wydział Farmaceutyczny

Immunological biomarkers of drug resistant epilepsy and response to immunomodulatory therapy with ACTH in children

Call: PRELUDIUM 6 , Panel: NZ4

Principal investigator: Magdalena Kaczorowska-Frontczak

Instytut "Pomnik - Centrum Zdrowia Dziecka"

Evaluation of the role of miRNA as a peripheral biomarker of drug resistance in epilepsy using biosensors for electroche...

Call: OPUS 27 , Panel: NZ5

Principal investigator: dr hab. Janusz Szyndler

Warszawski Uniwersytet Medyczny

A new universal method for the isolation and deep proteomic characterization of extracellular vesicles to study drug res...

Call: PRELUDIUM 23 , Panel: NZ2

Principal investigator: Bianka Świderska

Instytut Biochemii i Biofizyki Polskiej Akademii Nauk

Studies on the anticonvulsant activity of 4-alkyl-5-aryl-1,2,4-triazole-3-thione derivatives

Call: SONATA 6 , Panel: NZ7

Principal investigator: dr hab. Tomasz Plech

Uniwersytet Medyczny w Lublinie, Wydział Farmaceutyczny z Oddziałem Analityki Medycznej

Determination of the mechanisms and possibility of central nervous system regeneration using mesenchymal stem cells and ...

Call: OPUS 16 , Panel: NZ3

Principal investigator: prof. Marcin Majka

Uniwersytet Jagielloński – Collegium Medicum, Collegium Medicum, Wydział Lekarski